Free Trial!
Today’s Best Stocks To Trade! Click Here
China BAK Battery Inc. (NASDAQ: CBAK | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the manufacture, commercialization, and distribution of various standard and customized lithium ion rechargeable batteries in the People's Republic of China and internationally. The company manufactures a range of lithium ion rechargeable batteries, such as steel-case cells, aluminum-case cells, battery packs, cylindrical cells, high-power lithium-phosphate cells, and lithium polymer cells. Its products are used in cellular phone, camcorder, MP3/MP4 player, digital camera, digital video camera, PDA, blackberry, notebook computer, portable DVD player, portable gaming system, bluetooth headset, electric drill, miner's lamp, electric bicycle, hybrid electric vehicle, and general industrial applications. China BAK Battery, Inc. serves battery pack manufacturers, original equipment manufactures, and replacement battery manufacturers. The company was founded in 2001 and is based in Shenzhen, the People's Republic of China. With 53.22 million shares outstanding and 2.53 million shares declared short as of May 2008, there is a failure to deliver in shares of CBAK. According to quarterly data provided by the SEC, there were still 13,373 shares of CBAK that were failing-to-deliver as of September 26, 2007.
Columbia Laboratories Inc. (NASDAQ: CBRX | Quote | Chart | News | PowerRating) engages in the research, development, manufacture, and commercialization of women's healthcare and endocrinology products. It offers its products through the utilization of its bioadhesive delivery system technology. The company markets vaginal progesterone gel products to assist women who are infertile become pregnant in the United States, which include CRINONE 8% for technical procedures to reproductive endocrinologists; PROCHIEVE 8% to obstetricians and gynecologists; and PROCHIEVE 4% for treatment of secondary amenorrhea. It also provides vaginal gel women's products, such as Replens, a vaginal moisturizer for replenishment of vaginal moisture; RepHresh vaginal gel that eliminates vaginal odor; and Advantage-S, a female contraceptive gel. In addition, the company offers STRIANT, a testosterone buccal system for the treatment of hypogonadism in men; and Advance Formula Legatrin PM for the relief of occasional pain and sleeplessness associated with minor muscle aches. Further, it engages in clinical development activities of vaginally-administered lidocaine to prevent and treat dysmenorrheal, as well as vaginally-administered carbamide peroxide for treating vaginal infections; and testosterone progressive hydration vaginal tablet for women, which completed phase I trial. Columbia Laboratories has a development and license agreement with Ardana Biosciences, Ltd. to develop terbutaline vaginal gel product candidate for the treatment of infertility, dysmenorrheal, and endometriosis. The company was founded in 1986 and is based in Livingston, New Jersey. With 51.96 million shares outstanding and 1.57 million shares declared short as of May 2008, there is a failure to deliver in shares of CBRX. According to quarterly data provided by the SEC, there were still 26,480 shares of CBRX that were failing-to-deliver as of September 28, 2007.
China Direct Inc. (NASDAQ: CDS | Quote | Chart | News | PowerRating) operates as a management and advisory services company in the People's Republic of China and the United States. The company provides management advice, investment capital, business development services, strategic planning, macroeconomic industry analysis, and financial management services. It also offers consulting and advisory services comprising general business consulting, Chinese regulatory advice, translation services, formation of entities in the PRC, strategic alliances and partnerships, mergers and acquisitions, and corporate asset evaluation to public Chinese entities seeking to access the United States capital markets. In addition, the company, through its subsidiaries, produces and distributes magnesium products, such as pure magnesium ingots, magnesium powders, and magnesium scraps; sells and distributes industrial grade synthetic chemicals, such as glacial acetic acid and acetic acid derivatives, acrylic acid and acrylic ester, vinyl acetate-ethylene, and polyvinyl alcohol; and develops recycling technological applications and ancillary services related to the operations of refineries. China Direct, Inc. is based in Deerfield Beach, Florida. With 23.04 million shares outstanding and 2.08 million shares declared short as of May 2008, there is a failure to deliver in shares of CDS. According to quarterly data provided by the SEC, there were still 288,249 shares of CDS that were failing-to-deliver as of September 27, 2007.
China Fire & Security Group Inc. (NASDAQ: CFSG | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the design, development, manufacture, and sale of fire protection products and services for industrial customers in China. The company designs and installs fire protection systems to address various aspects of industrial fire safety from fire detection to fire system control and extinguishing. Its fire detecting products include linear heat detectors and optical heat detectors used in various industrial settings; infrared flame detectors and infrared detectors used in the petrochemical industry; combustible and inert gas detectors used in the petrochemical and coal industries; and inert gas extinguishers for electronic and telecom equipment. The company also provides fire alarm control devices, water mist/sprinkler systems, and maintenance services. It markets its industrial fire safety products and systems primarily to companies in the iron and steel, power, and petrochemical industries in China, as well as to the projects for highway and railway tunnels, wine distilleries, tobacco warehouses, and nuclear reactors. The company was founded in 1995 and is headquartered in Beijing, China. With 27.56 million shares outstanding and 1.74 million shares declared short as of May 2008, there is a failure to deliver in shares of CFSG.
Cougar Biotechnology Inc. (NASDAQ: CGRB | Quote | Chart | News | PowerRating) a development stage biopharmaceutical company, engages in the acquisition and development of therapeutics for the treatment of cancer in the United States. The company owns the rights to three clinical stage drug candidates, including CB-7630, a targeted inhibitor of the steroidal enzyme for the treatment of advanced prostate cancer patients; CB-3304, an inhibitor of microtubules and tubulin for the treatment of hematological malignancies; and CB-1089, an analog of vitamin D for the treatment of prostate cancer. It is also conducting preclinical development of CB-6604, an extended version of CB-3304 for in-vitro studies in breast cancer cells. The company was incorporated in 2003 and is based in Los Angles, California. With 20.57 million shares outstanding and 795,500 shares declared short as of May 2008, there is a failure to deliver in shares of CGRB. According to quarterly data provided by the SEC, there were still 15,276 shares of CGRB that were failing-to-deliver as of September 18, 2007.
Clean Energy Fuels Corp. (NASDAQ: CLNE | Quote | Chart | News | PowerRating) provides natural gas as an alternative fuel for vehicle fleets in the United States and Canada. It designs, builds, finances, and operates fueling stations and supplies compressed natural gas and liquefied natural gas. The company serves approximately 275 fleet customers operating 14,000 natural gas vehicles in public transit, refuse hauling, airports, taxis, seaports, and regional trucking markets. As of December 31, 2007, Clean Energy Fuels Corp. owned and operated 170 natural gas fueling stations in Arizona, California, Colorado, Maryland, Massachusetts, Nevada, New Mexico, New York, Texas, Washington, Georgia, Wyoming, and Canada. The company was incorporated in 2001 and is based in Seal Beach, California. With 44.3 million shares outstanding and 2.52 million shares declared short as of May 2008, there is a failure to deliver in shares of CLNE. According to quarterly data provided by the SEC, there were still 13,937 shares of CLNE that were failing-to-deliver as of September 26, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
